Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jon Khymn who wrote (310)	7/1/2000 2:55:25 PM
From: Edwin S. Fujinaka	Read Replies (2) \| Respond to of 668

When CBMI is folded into Curis (perhaps in August) they will have a genomics component to the company. Most of the current pop is just a sector bounce for biotech companies in general. I can hardly wait for the first analysts to review the prospects for Curis. If they can promote "regenerative medicine" as a discrete field, and Curis is labeled a leader, there could be a lot of new interest generated. This stock feels like a coiled spring just waiting to be released <G>.